3-羟基-4-硝基苯甲醇 | 61161-83-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 3-羟基-4-硝基苯甲醇
• 英文名称: 5-(hydroxymethyl)-2-nitrophenol
• CAS: 61161-83-9
• 化学式: C₇H₇NO₄
• mdl: MFCD00086342
• 分子量: 169.137
• InChiKey: YDFRYKXELURVHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  86.3
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2908999090
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P310,P330,P332+P313,P362,P403+P233,P405,P501
• 危险品运输编号：
  1759
• 危险性描述：
  H302,H315,H318,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-(Hydroxymethyl)-2-nitrophenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-(Hydroxymethyl)-2-nitrophenol
CAS number: 61161-83-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7NO4
Molecular weight: 169.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-羟基-4-硝基苯甲醇 在 sodium hydroxide 、 四溴化碳 、 三苯基膦 作用下， 以 二甲基亚砜 为溶剂， 生成 (3-羟基-4-硝基-苯基)-乙酸
  参考文献：
  名称：

  Structure−Activity Studies for a Novel Series of N-(Arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines Possessing Dual 5-HT Uptake Inhibiting and α₂-Antagonistic Activities

  摘要：

  In search of an alpha(2)-antagonist/5-HT uptake inhibitor as a potential new class of antidepressant with a more rapid onset of action, compound 3 was prepared and observed to possess high affinity for the alpha(2)-receptor (K-i = 6.71 nM) and the 5-HT uptake site (20.6 nM). A series of tertiary amine analogs of 3 were synthesized and assayed for their affinity at both the alpha(2)-receptor and the 5-HT uptake site. The structure-activity relationship reveals that a variety of structural modifications to the arylethyl fragment are possible with retention of this dual activity. On the tetralin portion, 5-OMe substitution and the (R) stereochemistry at C-l are optimal with alternate substitutions producing compounds retaining high affinity for the alpha(2)-receptor but lacking affinity for the 5-HT uptake site. Data for several rigidified 5-O-alkyl analogs suggests that the favored orientation of the oxygen lone pairs may be away from the g-position of the tetralin.

  DOI：

  10.1021/jm960723m
• 作为产物：
  描述：

  3-羟基-4-硝基苯甲酸甲酯 在 sodium tetrahydroborate 、 三氯化铝 作用下， 以 二乙二醇二甲醚 为溶剂， 反应 0.5h， 生成 3-羟基-4-硝基苯甲醇
  参考文献：
  名称：

  Selivanov; Kulikov; Ginak, Russian Journal of Organic Chemistry, 1996, vol. 32, # 3, p. 394 - 400

  摘要：

  DOI：

文献信息

• Regioselective synthesis of benzimidazole thiophene inhibitors of polo-like kinase 1
  作者：Keith R. Hornberger、Jennifer G. Badiang、James M. Salovich、Kevin W. Kuntz、Kyle A. Emmitte、Mui Cheung

  DOI：10.1016/j.tetlet.2008.08.077

  日期：2008.10

  of novel 1-(2-thienyl)-benzimidazole inhibitors of polo-like kinase 1 is described. Amination of substituted 2-iodo or -bromo nitrobenzenes with a 2-aminothiophene derivative catalyzed by Pd2dba3 and XANTPHOS in the presence of excess Cs2CO3 afforded good yields of the coupled products. Subsequent reduction and cyclization of these intermediates provided the desired benzimidazole compounds.

  描述了新的1-（2-噻吩基）-苯并咪唑抑制剂的马球样激酶1的区域选择性合成。在过量的Cs 2 CO 3存在下，用Pd 2 dba 3和XANTPHOS催化的2-氨基噻吩衍生物对取代的2-碘或-溴硝基苯进行胺化，可得到良好的偶联产物收率。这些中间体的随后还原和环化提供了所需的苯并咪唑化合物。
• Benzimidazole Thiophene Compounds
  申请人：Kuntz Kevin

  公开号：US20080300247A1

  公开（公告）日：2008-12-04

  The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.

  本发明提供苯并咪唑噻吩化合物及含有该化合物的药物组合物，以及制备该化合物的方法和它们作为药物代理的用途。
• Tricyclic Indole-2-carboxylic Acids:  Highly in Vivo Active and Selective Antagonists for the Glycine Binding Site of the NMDA Receptor
  作者：Seiji Katayama、Nobuyuki Ae、Toru Kodo、Shuji Masumoto、Shinji Hourai、Chika Tamamura、Hiroyasu Tanaka、Ryu Nagata

  DOI：10.1021/jm020239l

  日期：2003.2.1

  3S-(-)-4 such as 3a, 3f, and 3g which had certain zwitterionic anilides showed high affinity to the NMDA-glycine binding site. The absolute configuration of 3S-(-)-4 was confirmed by X-ray crystallographic analysis. In particular, 3g (SM-31900) was found to be a highly active glycine antagonist for both in vitro and in vivo assays (K(i) = 1.0 +/- 0.1 nM, ED(50) = 2.3 mg/kg, iv) and also showed high

  合成了一系列三环吲哚-2-羧酸衍生物，并通过放射性配体结合测定和在小鼠NMDA诱发的癫痫发作模型中的抗惊厥作用进行了评估。在它们之中，具有某些两性离子苯甲酸酯的3S-（-）-4的衍生物，例如3a，3f和3g，显示出对NMDA-甘氨酸结合位点的高亲和力。通过X射线晶体学分析确认了3S-（-）-4的绝对构型。特别是，在体外和体内试验中，发现3g（SM-31900）是一种高活性甘氨酸拮抗剂（K（i）= 1.0 +/- 0.1 nM，ED（50）= 2.3 mg / kg，iv ），并且还显示出对甘氨酸位点的高选择性。此外，3g在水性介质中的溶解度足够（在pH 7.4时大于10 mg / mL），可用于静脉注射药物。
• [EN] SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF<br/>[FR] SYNTHÈSE DE COMPOSÉS ET DE DÉRIVÉS HYDROXYSTILBÈNE SUBSTITUÉS ET UTILISATIONS DE CEUX-CI
  申请人：KYNAN DUKE IP LLC

  公开号：WO2021127743A1

  公开（公告）日：2021-07-01

  The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.

  本公开涉及替代羟基芪类化合物及其衍生物，具体为2-取代羟基芪类化合物及其衍生物，这些化合物的合成以及它们在治疗中的应用。
• Novel chromogenic ligands for lithium and sodium based on calix[4]arene tetraesters
  作者：Mary McCarrick、Bei Wu、Steven J. Harris、Dermot Diamond、Geraldine Barrett、M. Anthony McKervey

  DOI：10.1039/c39920001287

  日期：——

  Two new chromogenic calix[4]arene tetraesters bearing nitrophenol residues display a striking cation-selective shift in absorbance maximum from the ultraviolet to the visible region in the presence of base upon addition of lithium ion or, to a lesser extent, sodium ion; the metal salt causes a change from colourless to yellow, the colour density being concentration dependent.

  两种新的含硝基酚残基的色谱型四羧酸钙克斯[4]芳烃四酯在碱存在下，加入锂离子或在较小程度上钠离子时，显示出显著的阳离子选择性吸光度最大值从紫外区向可见区的迁移；金属盐导致颜色从无色变为黄色，颜色的浓度依赖性。